In total, the cohort included 11 symptomatic heterozygous GRN mutation carriers (FTD-GRN; MC = mutation carrier), of which 3 patients were diagnosed with mild cognitive impairment (MCI) at the timepoint of CSF sampling. The gene discussed is GRN; the disease is frontotemporal dementia.